Sandra Le Quellec

11PUBLICATIONS
17CO-AUTHORS
Gene and molecular therapyMedical devicesAnimal protection (incl. pests and pathogens)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 06, 2025
Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years.

Annette von Drygalski, Esteban Gomez, Adam Giermasz

|Dec 09, 2022
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy.

Annette von Drygalski, Esteban Gomez, Adam Giermasz

|Jun 29, 2022
Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors.

Claude Négrier, Johannes Oldenburg, Gili Kenet

|Feb 05, 2022
Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: A retrospective single-centre study.

Stéphanie Désage, Yesim Dargaud, Sandrine Meunier

|Dec 17, 2021
Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?

Katharina Holstein, Sandra Le Quellec, Robert Klamroth

|Nov 20, 2020
Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.

Stéphanie Désage, Valérie Chamouard, Sandrine Meunier

Pageof 2

Frequent Collaborators

2 joint publications

Lucia Rugeri

2 joint publications

Stéphanie Désage

2 joint publications

Claude Négrier

1 joint publications

Mathilde Penel-Page